VentriPoint Diagnostics Ltd V.VPT

Financials Update:Focus on China

[GrahamB]

Will be heading off for a while for travel, but working through financials, and checking for updates in operations/plans/progress.

Questions:

Looking at updates to operations in the Chinese partnership from recent financials.

My approach is to compare yoy data to see how management has executed or not.

 

Main o principle is to use  facts to guide me…

In summary:

 

7 years since the YuTian Chinese partnership and licence announced.

 

Almost 2 1/2 years since sales announced and “Additional sales are in progress and will be announced

as they are completed over the coming months” was a statement from fall of 2020.

 

Comparing the moist recent annual finacials and MRQ, previously, I see no update to managements guidance in progress and no reports of sales in the last year, despite hearing it would be months to report these completed sales.

 

Clearly this is stalled from what was stated. 

To me, the follow-up in this area is devoid of important details.

Irrespective at this point, ny assessment is that execution in China has been stalled at best.

 

See below for relevant excepts from recent year end finacials and 2020 fro comparisons.

 

MDA sep 30th, 2020

 

Chinese Partnership and Future Development

The Company previously announced (see NR Nov 3, 2015) it had granted an exclusive license to develop

and manufacture knowledge-based reconstruction (“KBR”) products in the People’s Republic of China to

YuTian Medical Investment based in Shanghai and Yutian  Technology located in Ma'anshan. (“Yutian”).

Yutian has developed a series of products to specifically meet the demands of the Chinese market based

on the KBR technology and has received regulatory approval for the sale of the KBR-based products in

China. Billing codes for RV Ultrasound Quantitative Analysis were granted in November of 2019 and the

first two sales in China closed in December of 2019. Additional sales are in progress and will be announced

as they are completed over the coming months

 

Update Dec 31,2021 MD&A

 

Chinese Partnership and Future Development

On February 16, 2021, the Company announced that its joint-venture partner Yutian Medical Shanghai Inc.

("Yutian") had informed the Company that  it had achieved a number of milestones in its platform

development to commercialization.

 

Source:Sedar.com

[rkula15]

Once again thanks for taking care of us and thanks for your concern on a stock that upu don't even own. I hope you take care of all the shareholders of all the venture stocks. Venture stocks are a risk and we assume the risk, we know that. We are here for the potential. The definition of insanity is doing the same thing over and over again but expecting a different result. You must be insane

[jopatclo]

This post has been removed in accordance with Community Policy

[GrahamB]

Interesting and telling that the only response to a factual summary of the companies finacials is negative, to malign the poster, and to avoid discussing the consistent losses of the company, continued failure to make a single sale, and the lack of follow up on stated objectives of management.  Note that this data is company data posted on sedar. It isn't my data, it is company data

[rkula15]

Blah blah blah blah blah

[Pandora]

There are probably a dozen, two dozen, three dozen or more on here that recognize all the same stuff as you keep reciting but they do not incessantly post it to tick everybody off. They just accept it for what it is. Those that don't like it enough or can't take it they just leave quietly. They don't make persistent fools of themselves. Maybe you could do the same - we really don't

[GrahamB]

So ,if I understand you correctly, posting factual data and holding management acccountable to what they have stated as objectives, and guidance, using company published data should be quietly accepted. Yet, posters like jopatchglo that represent more than 50% of the posts(over 10 on my screen) are acceptable, when the substance of such posts are to spec ulate on a buyout, talk about lube, and

[rkula15]

Blah blah blah blah blah Enough already. We get it. Thank you for your concern. Go somewhere else and help some more people. You are a good person, we have benefited from your help enough. Other people deserve to get the same help. There must be other stocks on the venture with shareholders in need of your bs ... I mean help.

[Bihicellow]

Why don’t you SHUT UP 

[Pandora]

I pay no attention to his either, and if he gets over bearing - as he does quite often - I have the option of the ignore button. Every once in a while he finds something of interest but that is certainly in the minority of his posts. The Babble app won't even work on most of his content where he does some babbling. You each have an agenda. I filter it as I see fit.

[GrahamB]

"I pay no attention to his either, and if he gets over bearing - as he does quite often - I have the option of the ignore button. Every once in a while he finds something of interest but that is certainly in the minority of his posts. The Babble app won't even work on most of his content where he does some babbling. You each have an agenda. I filter it as I see fit." Fqir enough

[Pandora]

Just one last thing -- if you had any compassion for all of the people on this board you might temper your activities and at the same time try not to keep telling us you are the victim here and trying to convince us at the same time that you are only trying to save us fom ourselves. Most of us have been on these boards long enough to recognize that each and every board has at least one of you. And

[GrahamB]

Understood. I have read many,many small cap boards, and seldom post. Very few, have deep dives and analysis on financials. I came here at the request of old dog, when he messsaged me and also posted asking me to review one of the few other stocks I follow. The exercise for me is an intellectual one, and one in which I get a chance to review business fundamentals since there arent any analysts

[InvrsContrarian]

A step further in this study would be to introduce comparables. An article came out yesterday of a private medical device company in the Lower mainland going public in the near future, they had recently raised $100 million to further their development. They are opening up a new facility for their 100 plus employees, on their way to 200 employees. They have white papers being written and they are

[InvrsContrarian]

Article here: https://www.theglobeandmail.com/business/article-bc-medical-device-firm-raises-115-million-from-us-fund-giants-ahead-of/

[Pandora]

https://kardium.com/